Literature DB >> 14640396

Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections.

Stephen Taylor1, S Tariq Sadiq, Ian Weller, Steve Kaye, Judith Workman, Patricia A Cane, Julie Bennett, Andrew J Copas, Susan M Drake, Deenan Pillay.   

Abstract

Sexually transmitted infections may enhance the sexual transmission of HIV-1. It is possible that loss of virological control in patients with such infections receiving antiretroviral therapy (ART) may even facilitate the transmission of drug-resistant HIV. We have recently demonstrated that in those on maximally suppressive ART this effect is reduced. We have examined the virus obtained from the blood plasma and seminal plasma of six HIV-1-infected men receiving poorly suppressive ART with acute urethritis for the presence of drug resistance-associated mutations. In four men with gonorrhoea the blood and seminal plasma HIV-1 had mutations conferring reduced susceptibility to one or more available drugs. In one of these men the viral load of drug-resistant virus in seminal plasma was 20-fold higher during gonorrhoea than following antibiotic treatment, with no change in blood plasma viral load. We conclude that in the presence of suboptimal ART, sexually transmitted infections may enhance the spread of drug-resistant HIV-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14640396

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  6 in total

1.  Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men.

Authors:  Joseph A Politch; Kenneth H Mayer; Seth L Welles; William X O'Brien; Chong Xu; Frederick P Bowman; Deborah J Anderson
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

2.  The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy.

Authors:  S T Sadiq; S Taylor; A J Copas; J Bennett; S Kaye; S M Drake; S Kirk; D Pillay; I V D Weller
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

Review 3.  Antiviral agents and HIV prevention: controversies, conflicts, and consensus.

Authors:  Myron S Cohen; Kathryn E Muessig; M Kumi Smith; Kimberly A Powers; Angela D M Kashuba
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

4.  HIV-1 heterosexual transmission and association with sexually transmitted infections in the era of treatment as prevention.

Authors:  Marineide Gonçalves de Melo; Eduardo Sprinz; Pamina M Gorbach; Breno Santos; Tauí de Melo Rocha; Mariana Simon; Marcelo Almeida; Rita Lira; Maria Cristina Chaves; Tara Kerin; Ivana Varella; Karin Nielsen-Saines
Journal:  Int J Infect Dis       Date:  2019-08-09       Impact factor: 3.623

5.  Predictors of HIV Among 1 Million Clients in High-Risk Male Populations in Tanzania.

Authors:  Gaspar Mbita; Albert N Komba; Caterina Casalini; Eva Bazant; Kelly Curran; Alice Christensen; Daniel Nyato; Young-Mi Kim; Jason Reed; Neema Makyao; Upendo Kategile; Donaldson F Conserve; Diana Faini; Jos van Roosmalen; Thomas van den Akker
Journal:  AIDS Behav       Date:  2022-04-01

Review 6.  HIV infection of the male genital tract--consequences for sexual transmission and reproduction.

Authors:  A Le Tortorec; N Dejucq-Rainsford
Journal:  Int J Androl       Date:  2009-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.